GL1X · GenesisL1 explorer

Research workbench

Asymmetric htnf-alpha

Analyse Asymmetric htnf-alpha in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6OOY
Type
protein
Length
414 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tumor necrosis factor
UniProt
P01375
Ligands
A7M
Pockets
4 · best druggability 0.81

Structure

x-ray diffraction · 3 distinct chains · 1% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATumor necrosis factorprotein1400% helix, 56% strandP01375
BTumor necrosis factorprotein1402% helix, 55% strandP01375
CTumor necrosis factorprotein1340% helix, 55% strandP01375

Ligands and binding sites

  • A7M · {1-[(2,5-dimethylphenyl)methyl]-1H-benzimidazol-2-yl}methanol · ligand · chains A, B, C
  • MRD · (4R)-2-methylpentane-2,4-diol · additive · chains A, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13610.810.9045MRD, A7M
23420.660.8041empty
3530.500.8717empty
4880.450.8020empty

Interfaces

3 interfaces between chains.

  • B–C · 1058 Ų buried · 13 hydrogen bonds · protein-protein
  • A–B · 955 Ų buried · 8 hydrogen bonds · protein-protein
  • A–C · 466 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 6OOY · Asymmetric hTNF-alpha · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.